Dharmacon | 188进口试剂采购网

About Us

As leaders in custom RNA synthesis, Dharmacon Inc was an early participant in the newly discovered field of RNA interference, and contributed several key scientific findings and some of the first commercially available, guaranteed to-silence siRNA reagents. This leadership continued through technical advances in bioinformatics and chemical modifications to improve performance. Today, our areas of research and research tools have expanded to support all aspects of RNAi interference; siRNA, lentiviral shRNA, tools for microRNA research and genome scale libraries for RNAi functional screens of genes, microRNAs and long non-coding RNAs. For over-expression, GE Healthcare has one of the largest collections of cDNAs and ORFs commercially available.

More recently, GE Healthcare released a suite of innovative Dharmacon CRISPR-Cas9 gene editing tools, leveraging our leadership in RNA synthesis and vector biology, providing one of the most comprehensive genome engineering toolset available. Our approach in providing ready-to-use synthetic and lentiviral guide RNAs and Cas9 nuclease reagents greatly simplifies the selection of appropriate tools for nearly every application. Our bioinformatics expertise has resulted in the first rational design algorithm for CRISPR-Cas9 functional gene knockout, so predesigned, genome-wide guide RNAs for human, mouse, and rat are only a click away.

GE Healthcare Dharmacon Inc has been assessed and holds a certificate for ISO 9001:2008. This applies to the design and manufacture of RNA, DNA, and viral products for research and laboratory use, including RNA interference, gene expression, and gene editing


产品列表
上一页 ... 下一页
新闻动态
行业前沿
技术文章
最新产品

188进口试剂采购网 www.188bio.cn -中国试剂网,试剂网,化学试剂网,国药试剂,抗体公司,试剂公司,试剂盒公司,上海试剂公司,北京化学试剂公司,天津化学试剂,试剂商城,试剂代理,流式抗体 细胞库查询 sitemap